Metraipolis › archive › dc_3c8d7b512a42

CRISPR-mediated generation of a tumor-associated antigen-deficient Raji platform to investigate antigen loss in CAR-T cell therapy — Europe PMC PMID:41089529

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41089529
DOI
10.3389/fgeed.2025.1649993
License (as archived)
solo-consultazione
Archived
2026-11-09T17:28:47.439Z
SHA-256 of the archived text
b0f8248e99d6d5d3169e2cc97bb6e8b20b38aecf22dfa4c08c060787136c0608
Stable URL of this page
https://metraipolis.com/documento/dc_3c8d7b512a42

How to cite

CRISPR-mediated generation of a tumor-associated antigen-deficient Raji platform to investigate antigen loss in CAR-T cell therapy — Europe PMC PMID:41089529 — Europe PMC (en), https://europepmc.org/article/MED/41089529 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3c8d7b512a42 (Metraipolis archive dc_3c8d7b512a42, sha256 b0f8248e99d6d5d3169e2cc97bb6e8b20b38aecf22dfa4c08c060787136c0608)
BibTeX
@misc{dc3c8d7b512a42,
  title = {CRISPR-mediated generation of a tumor-associated antigen-deficient Raji platform to investigate antigen loss in CAR-T cell therapy — Europe PMC PMID:41089529},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41089529},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3c8d7b512a42; sha256 b0f8248e99d6d5d3169e2cc97bb6e8b20b38aecf22dfa4c08c060787136c0608},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41089529. Agents can read the archived copy with the MCP tool read_document.